Tech Sinks as Tariff Fears Take Center Stage

user
DoTrading
03-27

Major Index Performance (Wednesday): Dow Jones: -0.3% $S&P 500(.SPX)$ : -1.1% Nas $NASDAQ(.IXIC)$ : -2.0%

The market’s four-day winning streak came to an end as tariff fears sent investors back into risk-off mode.

Non-US Stocks Continue to Outperform

Q1 Performance:

  • Non-US Stocks: +8.1%

  • S&P 500: -2.9%

Q4 2024 Recap:

  • Non-US Stocks: -8.8%

  • S&P 500: +2.1%

Why it Matters:

  • The outperformance isn't just a mean reversion—it reflects policy-driven headwinds for U.S. markets.

  • U.S. small caps have been hit the hardest, reinforcing this trend.

Expect near-term U.S. underperformance, though long-term prospects remain positive.

Microsoft, Amazon, Nvidia: The Earnings Bellwethers

These three stocks make up 16% of the S&P 500 and are among Wall Street’s most recommended names.

Why they matter for Q1 earnings:

Big Tech earnings will be the ultimate test for market sentiment in Q1.

Tariff Shock: 25% Auto Tariffs Coming April 3

Trump confirmed a 25% tariff on global automotive imports.

Tariffs

  • This follows the April 2 “reciprocal tariffs” announcement on other goods.

  • Automakers hoped for a delay, lower rate, or exemptions—but got none.

  • 7M+ cars were imported to the U.S. in 2024.

  • 50%+ of parts in U.S.-assembled vehicles come from Canada & Mexico.

  • Massive cost increases could crush automaker profits and ripple across supply chains.

This is a potential inflationary shock—just as the Fed was getting comfortable.

Fed Warning: Tariff-Driven Inflation May Not Be “Transitory”

St. Louis Fed President Alberto Musalem:

  • Tariff effects aren't just one-time price hikes—they can trigger second-round inflationary impacts.

  • If fully implemented, proposed tariffs could:

    Increase U.S. effective tariff rate by 10%.

    Boost PCE inflation by up to 1.2 percentage points.

The Fed may have to rethink its rate-cut path if tariffs push inflation higher.

Rotation Watch: Health Care vs. Tech

Year-to-Date Performance:

  • Tech: Underperforming as macro risks rise.

  • Health Care: Leading as a defensive play.

  • Outperforms during macro uncertainty.

  • Less sensitive to tariffs & rate policy.

  • More stable earnings outlook.

The Tech-to-Health Care rotation could persist into Q2 as uncertainty rises.

Final Thought: Near-Term Headwinds, Long-Term Questions

The market has gone from Fed-driven optimism to tariff-driven fear. Investors need clarity on: 1) Tariff details & exemptions (April 2-3 announcements). 2) Q1 Tech earnings & AI demand (MSFT, AMZN, NVDA). 3) Fed’s response to rising inflation risks.

Short-Term Outlook: Volatility ahead—markets are still digesting the full impact of tariffs.

If you find this post interesting, give it wings! ️ Repost and share the insights. Do consider “Follow me” and get firsthand read of my daily new post. Thank you. 

@TigerStars @Tiger_SG @TigerCommunity @Tiger_comments @Daily_Discussion @TigerEvents

This summary is for informational purposes only and does not constitute financial advice. Investors should conduct their own research before making investment decisions. 
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1
2